Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maksim Mamonkin

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Blood|March 6, 2025
CD7 CAR-T: a bridge to transplant in AMLMaksim Mamonkin
Blood|September 21, 2020
Detonating T-ALLMaksim Mamonkin
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Off-the-Shelf Chimeric Antigen Receptor T Cells: How Do We Get There?Norihiro Watanabe, Maksim Mamonkin
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2024
SOHO State of the Art Updates and Next Questions | CAR T Cells in T Cell Acute Lymphoblastic Leukemia and Lymphoblastic LymphomaDaniil Shmidt, Maksim Mamonkin
Immunity|January 14, 2026
To the nines: IL-9 boosts T cell functionElizabeth Wickman, Maksim Mamonkin
Blood|September 4, 2025
CART-007: a license to killSwati Naik, Maksim Mamonkin
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2019
Generation of Chimeric Antigen Receptor T Cells Using Gammaretroviral VectorsFeiyan Mo, Maksim Mamonkin
Nature Medicine|February 8, 2017
Exhausting alloreactivity of donor-derived CAR T cellsMaksim Mamonkin, Helen E Heslop
Blood|July 28, 2022
CD7 CAR: sword and shieldM Paulina Velasquez, Maksim Mamonkin
Science (New York, N.Y.)|April 2, 2021
Reversal of exhaustion in engineered T cellsMaksim Mamonkin, Malcolm K Brenner
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Blood|March 6, 2025
CD7 CAR-T: a bridge to transplant in AMLMaksim Mamonkin
Blood|September 21, 2020
Detonating T-ALLMaksim Mamonkin
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Off-the-Shelf Chimeric Antigen Receptor T Cells: How Do We Get There?Norihiro Watanabe, Maksim Mamonkin
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2024
SOHO State of the Art Updates and Next Questions | CAR T Cells in T Cell Acute Lymphoblastic Leukemia and Lymphoblastic LymphomaDaniil Shmidt, Maksim Mamonkin
Immunity|January 14, 2026
To the nines: IL-9 boosts T cell functionElizabeth Wickman, Maksim Mamonkin
Blood|September 4, 2025
CART-007: a license to killSwati Naik, Maksim Mamonkin
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2019
Generation of Chimeric Antigen Receptor T Cells Using Gammaretroviral VectorsFeiyan Mo, Maksim Mamonkin
Nature Medicine|February 8, 2017
Exhausting alloreactivity of donor-derived CAR T cellsMaksim Mamonkin, Helen E Heslop
Blood|July 28, 2022
CD7 CAR: sword and shieldM Paulina Velasquez, Maksim Mamonkin
Science (New York, N.Y.)|April 2, 2021
Reversal of exhaustion in engineered T cellsMaksim Mamonkin, Malcolm K Brenner
Pageof 6